Our unwavering commitment to our patients requires that we act responsibly on all fronts. Our actions are for the benefit of the patients we serve around the world, our company, our employees, our shareholders and our communities.
2022 ESG report
Our 2022 environmental, social, and governance (ESG) report details our ESG goals, strategies, and progress and, equally important, our approach to working with a common purpose.
We continue the quest to increase access to medicines for those in need through research and development, our partnership with patients, advocacy groups, healthcare providers, industry, governments and NGOs, and our focus on healthcare infrastructure, product quality and safety.